Tuberculosis treatment outcome and health services: a comparison of displaced and settled population groups in Khartoum, Sudan.
METHODS
The Sudan National Tuberculosis Programme serves internally displaced and settled populations in Khartoum, Sudan.


OBJECTIVE
To investigate whether treatment in the camps is satisfactory compared to the settled population and to World Health Organization (WHO) standards, and to map certain characteristics of the clinics that may explain differences in treatment outcome.


METHODS
A register analysis was done on sputum smear-positive and retreatment tuberculosis patients registered consecutively in the first and second quarters of 2000. The nine health facilities from which the patients were selected were investigated using a questionnaire. State tuberculosis officers were interviewed about regional treatment policies.


RESULTS
Two hundred and ninety-five internally displaced and 154 settled patients from respectively five and four clinics were included. The cure and completion rates among new sputum smear-positive cases were significantly higher among displaced (65% and 9.3%) than among settled persons (43.5% and 21%). Displaced groups had better adherence to 5 and 8 month smear examinations, and the quantity of health education was higher in the camps than among the settled population.


CONCLUSIONS
Tuberculosis treatment among the displaced population in Khartoum compares favourably with the neighbouring settled population, but both groups still face serious challenges to fulfil the WHO goals.
Bøhler
M
M
Faculty of Medicine, University of Bergen, Bergen, Norway. bohler@student.uib.no
Mustafaa
S A
SA
Mørkve
O
O
D000328:Adult; D000995:Antitubercular Agents / Q000627:therapeutic use*; D005260:Female; D019538:Health Care Surveys; D006297:Health Services Accessibility; D006801:Humans; D008297:Male; D010349:Patient Compliance; D010353:Patient Education as Topic; D011787:Quality of Health Care; D012036:Refugees; D013183:Sputum / Q000382:microbiology; D013397:Sudan; D016896:Treatment Outcome; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*; D014944:World Health Organization
D000995:Antitubercular Agents